Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nepadutant in Infant Colic
NCT01309009Phase 2Withdrawn
- Sponsor
- Menarini Group
- Start
- Feb 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules, Cyclic Peptides
01
Overview
Phase 2, randomised, double-blind trial of nepadutant in infantile colic (3 arms), sponsored by Menarini Group. Primary endpoint: Absolute change of the mean daily crying and fussing time at 1 week. Planned start Feb 2011; status: withdrawn.
02
Drugs
nepadutant
03
Conditions
infantile colic
Beyond the preview
Go deeper on NCT01309009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01309009.